Patent · US Active

Peptides and methods for the treatment of diabetes

US10808016B2 · kind B2 · utility

3Cited by

4References

10Claims

0Family size

Assignee

IMCYSE SA · BE

Inventors

Luc Vander Elst · Obaix, BE
Vincent Carlier · Énines, BE
Jean-Marie Saint-Remy · Grez-Doiceau, BE

Key dates

Filing date	Aug 5, 2019
Grant date	Oct 20, 2020
Priority date	—
Expiry date	Aug 5, 2039

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/577
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to peptides such as HCPYCSLQPLALEGSLQKRG and their use in the treatment of type 1 diabetes and the generation of cytolytic CD4+ T cell.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.